Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties
about
Structural analysis of trimeric phospholipase A2 neurotoxin from the Australian taipan snake venomPolydatin up-regulates Clara cell secretory protein to suppress phospholipase A2 of lung induced by LPS in vivo and in vitroMetabolomic patterns and alcohol consumption in African Americans in the Atherosclerosis Risk in Communities StudyIntestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusionMembrane lipid interactions in intestinal ischemia/reperfusion-induced InjuryInhibitory effect of platinum and ruthenium bipyridyl complexes on porcine pancreatic phospholipase A2.Metabolomics predicts stroke recurrence after transient ischemic attack.Proteomic profiling of adipose tissue from Zmpste24-/- mice, a model of lipodystrophy and premature aging, reveals major changes in mitochondrial function and vimentin processing.Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairmentA novel fasting blood test for insulin resistance and prediabetes.Characterization of a metabolomic profile associated with responsiveness to therapy in the acute phase of septic shock.Novel biomarkers for prediabetes, diabetes, and associated complications.Cross-sectional and dynamic change of serum metabolite profiling for Hepatitis B-related acute-on-chronic liver failure by UPLC/MS.Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.Lysophosphatidylcholines: bioactive lipids generated during storage of blood components.Antiseptic Activity of Ethnomedicinal Xuebijing Revealed by the Metabolomics Analysis Using UHPLC-Q-Orbitrap HRMS.An Innovative Approach for The Integration of Proteomics and Metabolomics Data In Severe Septic Shock Patients Stratified for Mortality.Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury: a pilot, randomized safety and feasibility trial
P2860
Q27681730-4666B5A1-71A6-47F9-98B7-469E8052BFB0Q28580811-277909B3-B789-4A70-889B-C08EE1358968Q33614788-A54C2224-212E-4A09-9405-5391F20084BDQ33678586-A1CBDA90-298E-4236-B747-0BB28771EEE5Q33902557-D93A18B0-8EF2-4FA7-AC5E-8935116E121AQ34016733-57420C67-0B8E-43D0-9045-38CF19C34888Q35106564-CD40D91F-7420-4D9F-8942-8CA81737AD15Q35579609-AB9B6332-CBC6-4300-80C9-9E61CE3E589BQ36088639-BE0AF313-F47E-4AE6-A32B-B6F98B863AC2Q36145180-1DD37E89-230E-4924-BF76-BFFBAC8CB90DQ36428387-1032FEB2-CA33-4501-9FAF-A62DA8565687Q36954280-2DD1D63B-7D7C-4F62-8A74-D893586835EAQ40075609-73D48563-3B21-4A65-AF84-7585B85420A7Q41475816-B5422629-EB0B-4A76-9FEE-130CD12BCB67Q42249705-633CC8D5-8E4A-4007-8497-DD62A2791485Q47357441-CD63D7FB-D14F-4A4F-AB0A-A469A29280D0Q50520711-371B4D95-7AA7-4791-86B9-287A4C40B944Q52590805-797D2F35-079E-4676-B5D1-929BFBA5933EQ53821170-71E71C5C-0812-4C1C-8619-EA203C9336E7Q57071565-7AECD66F-1084-4FE7-8BE5-8477FDA7EB30
P2860
Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Product inhibition of secreted ...... xpected therapeutic properties
@en
type
label
Product inhibition of secreted ...... xpected therapeutic properties
@en
prefLabel
Product inhibition of secreted ...... xpected therapeutic properties
@en
P2093
P2860
P356
P1476
Product inhibition of secreted ...... xpected therapeutic properties
@en
P2093
Angel Lucena
Timothy J Cunningham
P2860
P2888
P356
10.1186/1476-9255-5-17
P577
2008-10-22T00:00:00Z
P5875
P6179
1050894916